Component

Human free fatty acid receptor 2 / FFAR2

Context-specific entity; species, compartment and exposure are stated on each claim.

10 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Short-chain fatty acid-mediated activation of GPR43 suppressed insulin signalling in adipocytes, which inhibited fat accumulation in adipose tissue and promoted the metabolism of unincorporated lipids and glucose in other tissues, establishing GPR43 as a sensor for excessive dietary energy.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/23652017.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60", "start_char": 0, "end_char": 1122, "text_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60"}
    experimental_model
    GPR43-deficient and adipose-overexpressing mice, raised conventionally, germ-free and after antibiotics
    exposure
    Normal and high-fat diet, with germ-free rearing and antibiotic treatment as controls
    limitations
    The germ-free control is what ties the receptor phenotype to microbial short-chain fatty acids rather than to the receptor alone. The receptor senses all short-chain fatty acids, not acetate specifically.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Mouse
    plain_language
    The signal tells fat cells to stop taking on more, and sends the fuel elsewhere.
    primary_references
    [acetate-p23652017] The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. (2013). https://pubmed.ncbi.nlm.nih.gov/23652017/ DOI: 10.1038/ncomms2852
    tissue_or_cell_type
    Adipose tissue and whole body

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 264–275

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · GPR43-deficient and adipose-overexpressing mice, raised conventionally, germ-free and after antibiotics · source_derived_draft · unverified_draft

    ### acetate-ffar2-insulin-signalling Short-chain fatty acid-mediated activation of GPR43 suppressed insulin signalling in adipocytes, which inhibited fat accumulation in adipose tissue and promoted the metabolism of unincorporated lipids and glucose in other tissues, establishing GPR43 as a sensor for excessive dietary energy. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: The signal tells fat cells to stop taking on more, and sends the fuel elsewhere. organism: Mouse tissue_or_cell_type: Adipose tissue and whole body experimental_model: GPR43-deficient and adipose-overexpressing mice, raised conventionally, germ-free and after antibiotics limitations: The germ-free control is what ties the receptor phenotype to microbial short-chain fatty acids rather than to the receptor alone. The receptor senses all short-chain fatty acids, not acetate specifically. exposure: Normal and high-fat diet, with germ-free rearing and antibiotic treatment as controls evidence_span: {"source_cache": "artifacts/acetate-research/23652017.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60", "start_char": 0, "end_char": 1122, "text_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60"} [acetate-p23652017] The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. (2013). https://pubmed.ncbi.nlm.nih.gov/23652017/ DOI: 10.1038/ncomms2852
    Complete structured claim and evidence
  2. The FFAR2 reporter was strongly expressed in a large population of leukocytes in the lamina propria, particularly of the small intestine, but surprisingly only weakly in a subpopulation of enteroendocrine cells; nevertheless synthetic ligands specific for either FFAR3 or FFAR2 each released GLP-1 from colonic crypt cultures.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/23885020.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b834455e11c2b8fa3c4c19c5d01375815e46c3b0f8e25eb184f0eaa6a51c749e", "start_char": 0, "end_char": 2144, "text_sha256": "b834455e11c2b8fa3c4c19c5d01375815e46c3b0f8e25eb184f0eaa6a51c749e"}
    experimental_model
    Transgenic monomeric red fluorescent protein reporter mice with FACS purification and quantitative PCR
    exposure
    Cell-type resolved expression of FFAR2 and FFAR3 reporters, with receptor-specific synthetic agonists on colonic crypt cultures
    limitations
    Reporter expression is not the same as receptor protein. The FFAR2 result here is weaker in enteroendocrine cells than the rat immunohistochemistry in this collection reports.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Mouse
    plain_language
    FFAR2 turned out to sit mainly on immune cells rather than on the hormone cells, though its agonist still released the hormone.
    primary_references
    [acetate-p23885020] GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. (2013). https://pubmed.ncbi.nlm.nih.gov/23885020/ DOI: 10.1210/en.2013-1142
    tissue_or_cell_type
    Whole gastrointestinal tract

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 303–314

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transgenic monomeric red fluorescent protein reporter mice with FACS purification and quantitative PCR · source_derived_draft · unverified_draft

    ### acetate-ffar2-mostly-leukocytes The FFAR2 reporter was strongly expressed in a large population of leukocytes in the lamina propria, particularly of the small intestine, but surprisingly only weakly in a subpopulation of enteroendocrine cells; nevertheless synthetic ligands specific for either FFAR3 or FFAR2 each released GLP-1 from colonic crypt cultures. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: FFAR2 turned out to sit mainly on immune cells rather than on the hormone cells, though its agonist still released the hormone. organism: Mouse tissue_or_cell_type: Whole gastrointestinal tract experimental_model: Transgenic monomeric red fluorescent protein reporter mice with FACS purification and quantitative PCR limitations: Reporter expression is not the same as receptor protein. The FFAR2 result here is weaker in enteroendocrine cells than the rat immunohistochemistry in this collection reports. exposure: Cell-type resolved expression of FFAR2 and FFAR3 reporters, with receptor-specific synthetic agonists on colonic crypt cultures evidence_span: {"source_cache": "artifacts/acetate-research/23885020.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b834455e11c2b8fa3c4c19c5d01375815e46c3b0f8e25eb184f0eaa6a51c749e", "start_char": 0, "end_char": 2144, "text_sha256": "b834455e11c2b8fa3c4c19c5d01375815e46c3b0f8e25eb184f0eaa6a51c749e"} [acetate-p23885020] GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. (2013). https://pubmed.ncbi.nlm.nih.gov/23885020/ DOI: 10.1210/en.2013-1142
    Complete structured claim and evidence
  3. GPR43 immunoreactivity was localised to enteroendocrine cells expressing peptide YY, whereas 5-hydroxytryptamine-immunoreactive enteroendocrine cells were not immunoreactive for GPR43, and mast cells of the lamina propria expressing 5-hydroxytryptamine were also GPR43-immunoreactive.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/16453106.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "14165574bceda6c6197de30baae79895b87d2b95272ea42c231554d7a4c015d2", "start_char": 0, "end_char": 1605, "text_sha256": "14165574bceda6c6197de30baae79895b87d2b95272ea42c231554d7a4c015d2"}
    experimental_model
    RT-PCR, Western blotting and immunohistochemistry with a rat-specific GPR43 antiserum
    exposure
    Receptor localisation across mucosal cell types
    limitations
    An anatomical result naming the cells that carry the receptor. Localisation is not function, and the antiserum was raised against a synthesised fragment.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Rat
    plain_language
    The receptor sits on the gut cells that make PYY, and on mast cells, but not on the serotonin-making gut cells.
    primary_references
    [acetate-p16453106] Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. (2006). https://pubmed.ncbi.nlm.nih.gov/16453106/ DOI: 10.1007/s00441-005-0140-x
    tissue_or_cell_type
    Distal ileum and colon

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 277–288

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · RT-PCR, Western blotting and immunohistochemistry with a rat-specific GPR43 antiserum · source_derived_draft · unverified_draft

    ### acetate-ffar2-on-pyy-cells GPR43 immunoreactivity was localised to enteroendocrine cells expressing peptide YY, whereas 5-hydroxytryptamine-immunoreactive enteroendocrine cells were not immunoreactive for GPR43, and mast cells of the lamina propria expressing 5-hydroxytryptamine were also GPR43-immunoreactive. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: The receptor sits on the gut cells that make PYY, and on mast cells, but not on the serotonin-making gut cells. organism: Rat tissue_or_cell_type: Distal ileum and colon experimental_model: RT-PCR, Western blotting and immunohistochemistry with a rat-specific GPR43 antiserum limitations: An anatomical result naming the cells that carry the receptor. Localisation is not function, and the antiserum was raised against a synthesised fragment. exposure: Receptor localisation across mucosal cell types evidence_span: {"source_cache": "artifacts/acetate-research/16453106.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "14165574bceda6c6197de30baae79895b87d2b95272ea42c231554d7a4c015d2", "start_char": 0, "end_char": 1605, "text_sha256": "14165574bceda6c6197de30baae79895b87d2b95272ea42c231554d7a4c015d2"} [acetate-p16453106] Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. (2006). https://pubmed.ncbi.nlm.nih.gov/16453106/ DOI: 10.1007/s00441-005-0140-x
    Complete structured claim and evidence
  4. GPR43-deficient mice were obese on a normal diet whereas mice overexpressing GPR43 specifically in adipose tissue remained lean even when fed a high-fat diet, and raised under germ-free conditions or after treatment with antibiotics both types of mice had a normal phenotype.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/acetate-research/23652017.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60", "start_char": 0, "end_char": 1122, "text_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60"}
    experimental_model
    GPR43-deficient and adipose-overexpressing mice, raised conventionally, germ-free and after antibiotics
    exposure
    Normal and high-fat diet, with germ-free rearing and antibiotic treatment as controls
    limitations
    The germ-free control is what ties the receptor phenotype to microbial short-chain fatty acids rather than to the receptor alone. The receptor senses all short-chain fatty acids, not acetate specifically.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Mouse
    plain_language
    The receptor keeps fat off, and only when gut bacteria are there to supply its signal.
    primary_references
    [acetate-p23652017] The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. (2013). https://pubmed.ncbi.nlm.nih.gov/23652017/ DOI: 10.1038/ncomms2852
    tissue_or_cell_type
    Adipose tissue and whole body
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 251–262

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · GPR43-deficient and adipose-overexpressing mice, raised conventionally, germ-free and after antibiotics · source_derived_draft · unverified_draft

    ### acetate-ffar2-suppresses-fat GPR43-deficient mice were obese on a normal diet whereas mice overexpressing GPR43 specifically in adipose tissue remained lean even when fed a high-fat diet, and raised under germ-free conditions or after treatment with antibiotics both types of mice had a normal phenotype. Condition category: machinery_impairment nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: The receptor keeps fat off, and only when gut bacteria are there to supply its signal. organism: Mouse tissue_or_cell_type: Adipose tissue and whole body experimental_model: GPR43-deficient and adipose-overexpressing mice, raised conventionally, germ-free and after antibiotics limitations: The germ-free control is what ties the receptor phenotype to microbial short-chain fatty acids rather than to the receptor alone. The receptor senses all short-chain fatty acids, not acetate specifically. exposure: Normal and high-fat diet, with germ-free rearing and antibiotic treatment as controls evidence_span: {"source_cache": "artifacts/acetate-research/23652017.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60", "start_char": 0, "end_char": 1122, "text_sha256": "52bcd2cce838e217b7115f23092863912a2fad5dbece809485fa06c9c06d8d60"} [acetate-p23652017] The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. (2013). https://pubmed.ncbi.nlm.nih.gov/23652017/ DOI: 10.1038/ncomms2852
    Complete structured claim and evidence
  5. A FFAR2- and FFAR3-specific agonist had no effect on colonic GLP-1 output and a FFAR3 antagonist did not decrease the short-chain fatty acid-induced GLP-1 response, whereas the calcium channel blocker nifedipine, the KATP-channel opener diazoxide and the ATP synthesis inhibitor 2,4-dinitrophenol completely abolished the responses, leading the authors to conclude that the fatty acids are metabolised and function as a colonocyte energy source rather than acting through the receptors.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/29494208.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126", "start_char": 0, "end_char": 2445, "text_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126"}
    experimental_model
    Isolated perfused rat colon with luminal and vascular short-chain fatty acid infusion and receptor pharmacology
    exposure
    Acetate, propionate and butyrate perfused luminally or vascularly, with FFAR2/FFAR3 agonists, an FFAR3 antagonist, nifedipine, diazoxide and 2,4-dinitrophenol
    limitations
    An isolated organ preparation with an intact blood supply. It reaches the opposite mechanistic conclusion from the knockout work in this collection and is why the receptor route is recorded as disputed.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Rat
    plain_language
    Blocking the receptors changed nothing, while blocking energy production abolished the response.
    primary_references
    [acetate-p29494208] The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. (2018). https://pubmed.ncbi.nlm.nih.gov/29494208/ DOI: 10.1152/ajpgi.00346.2017
    tissue_or_cell_type
    Colon

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 342–353

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isolated perfused rat colon with luminal and vascular short-chain fatty acid infusion and receptor pharmacology · source_derived_draft · unverified_draft

    ### acetate-receptor-not-required A FFAR2- and FFAR3-specific agonist had no effect on colonic GLP-1 output and a FFAR3 antagonist did not decrease the short-chain fatty acid-induced GLP-1 response, whereas the calcium channel blocker nifedipine, the KATP-channel opener diazoxide and the ATP synthesis inhibitor 2,4-dinitrophenol completely abolished the responses, leading the authors to conclude that the fatty acids are metabolised and function as a colonocyte energy source rather than acting through the receptors. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: Blocking the receptors changed nothing, while blocking energy production abolished the response. organism: Rat tissue_or_cell_type: Colon experimental_model: Isolated perfused rat colon with luminal and vascular short-chain fatty acid infusion and receptor pharmacology limitations: An isolated organ preparation with an intact blood supply. It reaches the opposite mechanistic conclusion from the knockout work in this collection and is why the receptor route is recorded as disputed. exposure: Acetate, propionate and butyrate perfused luminally or vascularly, with FFAR2/FFAR3 agonists, an FFAR3 antagonist, nifedipine, diazoxide and 2,4-dinitrophenol evidence_span: {"source_cache": "artifacts/acetate-research/29494208.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126", "start_char": 0, "end_char": 2445, "text_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126"} [acetate-p29494208] The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. (2018). https://pubmed.ncbi.nlm.nih.gov/29494208/ DOI: 10.1152/ajpgi.00346.2017
    Complete structured claim and evidence
  6. Propionate stimulated secretion of both peptide YY and GLP-1 from wild-type murine colonic crypt cultures and this effect was significantly attenuated in cultures from FFA2 knockout mice, while intra-colonic infusion of propionate elevated both hormones in portal vein plasma in rats and mice but did not significantly stimulate their release in FFA2 knockout mice.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/25109781.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c3c934644f9308be7b2c26f969858debd0d1dbf19bee7e307e529d392fe135d6", "start_char": 0, "end_char": 1621, "text_sha256": "c3c934644f9308be7b2c26f969858debd0d1dbf19bee7e307e529d392fe135d6"}
    experimental_model
    Wistar rats, C57BL6 mice and FFA2 knockout mice, with colonic crypt cultures and portal vein sampling
    exposure
    Propionate applied to colonic crypt cultures and infused into the colon, with FFA2 deletion as the test of mediation
    limitations
    Establishes the receptor-to-hormone step in rodents using propionate rather than acetate. The knockout is the strength of the design.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Rat and mouse
    plain_language
    In rodents the receptor is what releases the two gut hormones; delete it and the response goes.
    primary_references
    [acetate-p25109781] The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. (2015). https://pubmed.ncbi.nlm.nih.gov/25109781/ DOI: 10.1038/ijo.2014.153
    tissue_or_cell_type
    Colon

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 316–327

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Wistar rats, C57BL6 mice and FFA2 knockout mice, with colonic crypt cultures and portal vein sampling · source_derived_draft · unverified_draft

    ### acetate-scfa-glp1-rodent Propionate stimulated secretion of both peptide YY and GLP-1 from wild-type murine colonic crypt cultures and this effect was significantly attenuated in cultures from FFA2 knockout mice, while intra-colonic infusion of propionate elevated both hormones in portal vein plasma in rats and mice but did not significantly stimulate their release in FFA2 knockout mice. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: In rodents the receptor is what releases the two gut hormones; delete it and the response goes. organism: Rat and mouse tissue_or_cell_type: Colon experimental_model: Wistar rats, C57BL6 mice and FFA2 knockout mice, with colonic crypt cultures and portal vein sampling limitations: Establishes the receptor-to-hormone step in rodents using propionate rather than acetate. The knockout is the strength of the design. exposure: Propionate applied to colonic crypt cultures and infused into the colon, with FFA2 deletion as the test of mediation evidence_span: {"source_cache": "artifacts/acetate-research/25109781.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c3c934644f9308be7b2c26f969858debd0d1dbf19bee7e307e529d392fe135d6", "start_char": 0, "end_char": 1621, "text_sha256": "c3c934644f9308be7b2c26f969858debd0d1dbf19bee7e307e529d392fe135d6"} [acetate-p25109781] The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. (2015). https://pubmed.ncbi.nlm.nih.gov/25109781/ DOI: 10.1038/ijo.2014.153
    Complete structured claim and evidence

What acts on it

  1. Butyrate activated human GPR43/FFAR2 in the receptor-deorphanization assays.

    Butyrate → Human free fatty acid receptor 2 / FFAR2 source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human receptor expressed in yeast, mammalian cells and oocyte signaling systems.
    limitations
    Receptor activation alone does not establish a downstream clinical effect.
    nutrient_topic
    Butyrate collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Butyrate
    plain_language
    One cell-surface receptor detects short-chain fatty acids.
    primary_references
    The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12496283/ · DOI 10.1074/jbc.M211609200

    Butyrate: microbial production, fuel use, signaling and nutrient interactions (2026-09-19) · lines 502–508

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human receptor expressed in yeast, mammalian cells and oocyte signaling systems. · source_derived_draft · unverified_draft

    ## butyrate-ffar2-agonist One cell-surface receptor detects short-chain fatty acids. Butyrate activated human GPR43/FFAR2 in the receptor-deorphanization assays. Model: Human receptor expressed in yeast, mammalian cells and oocyte signaling systems. Limitations: Receptor activation alone does not establish a downstream clinical effect. Evidence access: Primary abstract The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12496283/ · DOI 10.1074/jbc.M211609200
    Complete structured claim and evidence
  2. The acetate anion was identified as an agonist of human GPR43 during ligand bank screening in yeast and confirmed after transient transfection using calcium mobilisation and GTP-gamma-S binding assays and by coexpression with GIRK potassium channels in Xenopus oocytes, with formate, propionate, butyrate and pentanoate also showing agonist activity.

    Acetate → Human free fatty acid receptor 2 / FFAR2 source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/12496283.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "83f7777cab02a7c69f063d21e26f895884724f46ad539ebc767d9e6f371bf64f", "start_char": 0, "end_char": 1291, "text_sha256": "83f7777cab02a7c69f063d21e26f895884724f46ad539ebc767d9e6f371bf64f"}
    experimental_model
    Ligand bank screening in yeast, confirmed by calcium mobilisation, GTP-gamma-S binding and oocyte coexpression
    exposure
    Short chain carboxylic acid anions applied to recombinant GPR41 and GPR43
    limitations
    The deorphanising paper. Potencies come from recombinant systems, not from tissue, and the authors state plainly that the cognate physiological ligands are not clear.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Human and mouse receptors
    plain_language
    Acetate is not only fuel; it is the signal that identified this receptor.
    primary_references
    [acetate-p12496283] The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. (2003). https://pubmed.ncbi.nlm.nih.gov/12496283/ DOI: 10.1074/jbc.m211609200
    tissue_or_cell_type
    Transfected mammalian cells and Xenopus oocytes

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 225–236

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ligand bank screening in yeast, confirmed by calcium mobilisation, GTP-gamma-S binding and oocyte coexpression · source_derived_draft · unverified_draft

    ### acetate-acetate-activates-ffar2 The acetate anion was identified as an agonist of human GPR43 during ligand bank screening in yeast and confirmed after transient transfection using calcium mobilisation and GTP-gamma-S binding assays and by coexpression with GIRK potassium channels in Xenopus oocytes, with formate, propionate, butyrate and pentanoate also showing agonist activity. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: Acetate is not only fuel; it is the signal that identified this receptor. organism: Human and mouse receptors tissue_or_cell_type: Transfected mammalian cells and Xenopus oocytes experimental_model: Ligand bank screening in yeast, confirmed by calcium mobilisation, GTP-gamma-S binding and oocyte coexpression limitations: The deorphanising paper. Potencies come from recombinant systems, not from tissue, and the authors state plainly that the cognate physiological ligands are not clear. exposure: Short chain carboxylic acid anions applied to recombinant GPR41 and GPR43 evidence_span: {"source_cache": "artifacts/acetate-research/12496283.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "83f7777cab02a7c69f063d21e26f895884724f46ad539ebc767d9e6f371bf64f", "start_char": 0, "end_char": 1291, "text_sha256": "83f7777cab02a7c69f063d21e26f895884724f46ad539ebc767d9e6f371bf64f"} [acetate-p12496283] The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. (2003). https://pubmed.ncbi.nlm.nih.gov/12496283/ DOI: 10.1074/jbc.m211609200
    Complete structured claim and evidence
  3. Receptor studies confirmed acetate, propionate and butyrate to be low-potency partial agonists of FFAR2 compared with the synthetic agonist CFMB, which is a full agonist with roughly 750-fold higher potency than the short-chain fatty acids.

    Acetate → Human free fatty acid receptor 2 / FFAR2 source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/29494208.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126", "start_char": 0, "end_char": 2445, "text_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126"}
    experimental_model
    Isolated perfused rat colon with luminal and vascular short-chain fatty acid infusion and receptor pharmacology
    exposure
    Acetate, propionate and butyrate perfused luminally or vascularly, with FFAR2/FFAR3 agonists, an FFAR3 antagonist, nifedipine, diazoxide and 2,4-dinitrophenol
    limitations
    An isolated organ preparation with an intact blood supply. It reaches the opposite mechanistic conclusion from the knockout work in this collection and is why the receptor route is recorded as disputed.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Rat
    plain_language
    The natural fatty acids are weak at this receptor; a synthetic drug is hundreds of times stronger.
    primary_references
    [acetate-p29494208] The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. (2018). https://pubmed.ncbi.nlm.nih.gov/29494208/ DOI: 10.1152/ajpgi.00346.2017
    tissue_or_cell_type
    Colon

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 355–366

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isolated perfused rat colon with luminal and vascular short-chain fatty acid infusion and receptor pharmacology · source_derived_draft · unverified_draft

    ### acetate-weak-partial-agonism Receptor studies confirmed acetate, propionate and butyrate to be low-potency partial agonists of FFAR2 compared with the synthetic agonist CFMB, which is a full agonist with roughly 750-fold higher potency than the short-chain fatty acids. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: The natural fatty acids are weak at this receptor; a synthetic drug is hundreds of times stronger. organism: Rat tissue_or_cell_type: Colon experimental_model: Isolated perfused rat colon with luminal and vascular short-chain fatty acid infusion and receptor pharmacology limitations: An isolated organ preparation with an intact blood supply. It reaches the opposite mechanistic conclusion from the knockout work in this collection and is why the receptor route is recorded as disputed. exposure: Acetate, propionate and butyrate perfused luminally or vascularly, with FFAR2/FFAR3 agonists, an FFAR3 antagonist, nifedipine, diazoxide and 2,4-dinitrophenol evidence_span: {"source_cache": "artifacts/acetate-research/29494208.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126", "start_char": 0, "end_char": 2445, "text_sha256": "9f8def7b832fdd5d5aed67891c84b18b597d558d9361a92412ccc44264b88126"} [acetate-p29494208] The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. (2018). https://pubmed.ncbi.nlm.nih.gov/29494208/ DOI: 10.1152/ajpgi.00346.2017
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. GPR43 knockout mice had lower levels of intestinal IgA and of IgA-coated gut bacteria than wild-type mice, and feeding wild-type but not GPR43 knockout mice acetate, but not butyrate, promoted the intestinal IgA response independently of T cells.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/acetate-research/27966553.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "25ef476e62dd28f354099501d2919c3f765aaddd89d1a05739e3e0dc703d11ac", "start_char": 0, "end_char": 1363, "text_sha256": "25ef476e62dd28f354099501d2919c3f765aaddd89d1a05739e3e0dc703d11ac"}
    experimental_model
    GPR43 knockout mice with B-cell and dendritic-cell coculture and retinoic acid signalling blockade
    exposure
    Dietary acetate or butyrate in wild-type and GPR43 knockout mice, with in vitro IgA class switching assays
    limitations
    A clean set of controls: butyrate did not substitute for acetate, the effect was independent of T cells, and blocking the downstream vitamin A metabolite removed it.
    nutrient_topic
    Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. · Acetic acid
    organism
    Mouse
    plain_language
    Acetate tells the gut to make the antibody that coats its own bacteria, and butyrate does not stand in for it.
    primary_references
    [acetate-p27966553] Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. (2017). https://pubmed.ncbi.nlm.nih.gov/27966553/ DOI: 10.1038/mi.2016.114
    tissue_or_cell_type
    Intestinal mucosa

    Acetic acid: the ingested acid, the receptors acetate binds, the acetyl-CoA it becomes, and the acetyl groups that reach histones (2026-09-21) · lines 381–392

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · GPR43 knockout mice with B-cell and dendritic-cell coculture and retinoic acid signalling blockade · source_derived_draft · unverified_draft

    ### acetate-acetate-iga GPR43 knockout mice had lower levels of intestinal IgA and of IgA-coated gut bacteria than wild-type mice, and feeding wild-type but not GPR43 knockout mice acetate, but not butyrate, promoted the intestinal IgA response independently of T cells. Condition category: normal nutrient_topic: Acetic acid research collection; topical membership is not evidence of a direct clinical effect, and the ingested acid is recorded separately from the circulating acetate anion. plain_language: Acetate tells the gut to make the antibody that coats its own bacteria, and butyrate does not stand in for it. organism: Mouse tissue_or_cell_type: Intestinal mucosa experimental_model: GPR43 knockout mice with B-cell and dendritic-cell coculture and retinoic acid signalling blockade limitations: A clean set of controls: butyrate did not substitute for acetate, the effect was independent of T cells, and blocking the downstream vitamin A metabolite removed it. exposure: Dietary acetate or butyrate in wild-type and GPR43 knockout mice, with in vitro IgA class switching assays evidence_span: {"source_cache": "artifacts/acetate-research/27966553.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "25ef476e62dd28f354099501d2919c3f765aaddd89d1a05739e3e0dc703d11ac", "start_char": 0, "end_char": 1363, "text_sha256": "25ef476e62dd28f354099501d2919c3f765aaddd89d1a05739e3e0dc703d11ac"} [acetate-p27966553] Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. (2017). https://pubmed.ncbi.nlm.nih.gov/27966553/ DOI: 10.1038/mi.2016.114
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards